2024/06/04 16:59:33 | |
---|---|
Price | |
79.568 USD | |
Difference | 6.23% (4.67) |
ISIN | US0463531089 |
Symbol | AZN |
Exchange | London Stock Exchange |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 227,535 EUR |
Benchmark | FTSE 100 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 79.568 USD |
High | 79.568 USD |
Low | 79.568 USD |
Close (prev. day) | 74.90 USD |
VWAP | 79.568 USD |
Volume (pcs) | 310 |
Trading volume | 24,666.08 |
Number of trades | 1 |
Last size | 310 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/05/29 |
![]() |
Global Equity Ratings |
![]() |
2024/06/04 16:59:33 | |
---|---|
Price | |
79.568 USD | |
Difference | 6.23% (4.67) |
ISIN | US0463531089 |
Symbol | AZN |
Exchange | London Stock Exchange |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 227,535 EUR |
Benchmark | FTSE 100 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 79.568 USD |
High | 79.568 USD |
Low | 79.568 USD |
Close (prev. day) | 74.90 USD |
VWAP | 79.568 USD |
Volume (pcs) | 310 |
Trading volume | 24,666.08 |
Number of trades | 1 |
Last size | 310 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.81 | 0.93 | 0.76 |
Volatility | 2.54 | 4.26 | 5.29 |
Ø price 5 days | Ø volume 5 days (pcs.) | - USD (24) |
Ø price 30 days | Ø volume 30 days (pcs.) | - USD (50) |
Ø price 100 days | Ø volume 100 days (pcs.) | 71.395 USD (2,920) |
Ø price 250 days | Ø volume 250 days (pcs.) | 68.791 USD (6,347) |
YTD High | date | 79.568 USD (2024/06/04) |
YTD Low | date | 65.330 USD (2024/03/07) |
52 Weeks High | date | 79.568 USD (2024/06/04) |
52 Weeks Low | date | 62.050 USD (2023/10/27) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/07/31 | 15:30 | 73.00 EUR | 0.00 | 4 |
Tradegate | 2024/07/31 | 09:11 | 72.50 EUR | 0.01 | 2 |
Stuttgart | 2024/07/31 | 12:25 | 73.00 EUR | 0.00 | 2 |
Nasdaq | 2024/07/31 | 21:08 | 79.405 USD | 245.50 | 42,754 |
Munich | 2024/07/31 | 09:08 | 72.50 EUR | 0.00 | 1 |
London Stock Exchange | 2024/06/04 | 16:59 | 79.568 USD | 0.02 | 1 |
Frankfurt | 2024/07/31 | 08:14 | 72.00 EUR | 0.00 | 1 |
Duesseldorf | 2024/07/31 | 19:31 | 73.00 EUR | 0.00 | 5 |
Berlin | 2024/07/31 | 08:08 | 71.50 EUR | 0.00 | 1 |
ASTRAZENECA PLC |
- - |
Cambridge Biomedical Campus, 1 Francis Crick Avenue - CB2 0AA Cambridge |
Telefon: +44-20-3749-5000 |
Fax: + |
E-mail: - |
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. |
Pascal Soriot | Chairman of Managing Board |
Aradhana Sarin | Member of Executive Committee |
Ruud Dobber | Member of Executive Committee |
David Fredrickson | Member of Executive Committee |
Iskra Reic | Member of Executive Committee |
Jeff Pott | Member of Executive Committee |
Leon Wang | Member of Executive Committee |
Marc Dunoyer | Member of Executive Committee |
Menelas (Mene) Pangalos | Member of Executive Committee |
Pam Cheng | Member of Executive Committee |
Sharon Barr | Member of Executive Committee |
Susan Galbraith | Member of Executive Committee |
Michel Demaré | Chairman of Supervisory Board |
Andreas Rummelt | Member of Supervisory Board |
Aradhana Sarin | Member of Supervisory Board |
Euan Ashley | Member of Supervisory Board |
Nazneen Rahman | Member of Supervisory Board |
Shu Kam Mok | Member of Supervisory Board |
Anna Olive Magdelene Manz | Member of Supervisory Board |
Deborah DiSanzo | Member of Supervisory Board |
Diana Layfield | Member of Supervisory Board |
Marcus Wallenberg | Member of Supervisory Board |
Philip Broadley | Member of Supervisory Board |
Sherilyn McCoy | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer